Mobile app-based intervention and cardiovascular risk factors in patients with uncontrolled type 2 diabetes: a randomized clinical trial
Zhang PZ, Guo D, Liu CQ, et al.
JAMA Netw Open. Pub. online 2 Sep 2025.
Leggi
Breaking news
Automated insulin delivery systems and glucose management in children and adolescents with type 1 diabetes: a systematic review and meta-analysis
de Visser HS, Waraich S, Chhabra M, et al.
JAMA Pediatr. Pub. online 8 Sep 2025.
Leggi
Semaglutide treatment of antipsychotic-treated patients with schizophrenia, prediabetes, and obesity: the HISTORI randomized clinical trial
Ganeshalingam AA, Uhrenholt N, Arnfred S, et al.
JAMA Psychiatry. Pub. online 3 Sep 2025.
Leggi
Clinical features modifying the cardiovascular benefits of GLP-1 receptor agonists: a systematic review and meta-analysis
Kalayci A, Januzzi JL, Mitsunami M, et al.
Eur Heart J Cardiovasc Pharmacother. Pub. online 31 Aug 2025.
Leggi
FDA launches green list to protect americans from illegal imported GLP-1 drug ingredients
5 settembre 2025
Leggi
FDA’s concerns with unapproved GLP-1 drugs used for weight loss
5 settembre 2025
Leggi
EMA: warning about sharp rise in illegal medicines sold in the EU
3 settembre 2025
Leggi
AIFA: allerta sull’aumento di farmaci illegali venduti nell’UE come agonisti del recettore del GLP-1
4 settembre 2025
Leggi